Search Results

out of 31 results
DAWN | Drug Abuse Warning Network
Collected Date: 2019-2020
Report Type: Data Review or Analytical Report

This profile discusses ED visits related to alcohol.  The information provided in this profile summarizes unweighted data from a subset of 17 hospitals that have completed data abstraction on all ED visits related to alcohol from January through August 2020.

Part of the Preliminary DAWN Data Review Collection
DAWN | Drug Abuse Warning Network
Collected Date: 2019-2020
Report Type: Data Review or Analytical Report

This profile discusses substance-related ED visits before and during the response to COVID-19. The information provided below summarizes weekly unweighted data from a subset of 30 hospitals that fully participated in data abstraction from the first week of January through August 2020.

Part of the Preliminary DAWN Data Review Collection
DAWN | Drug Abuse Warning Network
Collected Date: 2019-2020
Report Type: Data Review or Analytical Report

This profile presents data on ED visits related to marijuana use. The information provided below summarizes unweighted data abstracted from 4/1/2019 to 10/15/2020.

Part of the Preliminary DAWN Data Review Collection
DAWN | Drug Abuse Warning Network
Collected Date: 2019-2020
Report Type: Data Review or Analytical Report

This profile presents data on ED visits related to methamphetamine use. The information provided below summarizes unweighted data abstracted from 4/1/2019 to 10/15/2020.

Part of the Preliminary DAWN Data Review Collection
DAWN | Drug Abuse Warning Network
Collected Date: 2019-2020
Report Type: Data Review or Analytical Report

This profile presents data on ED visits related to heroin and nonmedical use of prescription opioids (NMO). The information provided in this profile summarizes unweighted data abstracted from 4/1/2019 to 10/15/2020.

Part of the Preliminary DAWN Data Review Collection
DAWN | Drug Abuse Warning Network
Collected Date: 2019-2020
Report Type: Data Review or Analytical Report

This is a preliminary report on the Drug Abuse Warning Network (April 2019-October 2020). The Drug Abuse Warning Network (DAWN) is a nationwide public health surveillance system administered by the Substance Abuse and Mental Health Services Administration’s (SAMHSA’s) Center for Behavioral Health Statistics and Quality (CBHSQ). DAWN captures data on...

DAWN | Drug Abuse Warning Network
Collected Date: 2004-2011
Report Type: Short Report

This short report uses data from the Drug Abuse Warning Network (DAWN) to examine the emergency department (ED) visits for children aged 1 -5 that involved opioid pain relievers. Hydrocodone (Vicodin, Lortab), oxycodone (OxyContin, Percocet), and codeine are examples of opioid pain relievers; buprenorphine (Suboxone), is an opioid that is...

DAWN | Drug Abuse Warning Network
Collected Date: 2010-2013
Report Type: Short Report

This short report uses data from the AHRQ Healthcare Cost and Utilization Project Nationwide Emergency Department Sample (HCUP-NEDS) to assess the prevalence of underage alcohol misuse–related emergency department (ED) visits. Changes in the trends of alcohol-only and drug and alcohol-combination ED visits by age, gender and time are examined.

NSDUH | National Survey on Drug Use and Health, DAWN | Drug Abuse Warning Network, TEDS | Treatment Episode Data Set
Collected Date: 2007-2014
Report Type: Data Review or Analytical Report

This report presents facts about substance use among adults age 65 and older, including information on substance use on an average day, receipt of substance use treatment, and emergency department (ED) visits. This paper draws upon three SAMHSA data collections: the National Survey on Drug Use and Health (NSDUH), the...

DAWN | Drug Abuse Warning Network
Collected Date: 2004-2011
Report Type: Short Report

This short report uses data from the Drug Abuse Warning Network to examine when alcohol-related emergency department (ED) visits occurred, by time of day and day of the week. Data from a nationally-representative sample of non-Federal, general hospitals with 24-hour EDs was used, with combined data for 2004-2011. The pattern...

DAWN | Drug Abuse Warning Network
Collected Date: 2004-2011
Report Type: Short Report

This short report from the Drug Abuse Warning Network examines emergency department (ED) visits that involved a drug-related suicide attempt. It looks at the characteristics of the ED visits where the patient left against medical advice (before the ED visit was completed). It discusses how patients who left the ED...

DAWN | Drug Abuse Warning Network, TEDS | Treatment Episode Data Set
Collected Date: 2010-2014
Report Type: Short Report

There has been a significant increase in hospitalizations for opioid misuse in recent years. Using 2010-2014 MarketScan commercial data, this report finds that 40 percent of patients do not receive any follow-up services within 30 days after an opioid-related hospitalization. Only 11 percent of patients received the recommended combination of...

DAWN | Drug Abuse Warning Network
Collected Date: 2005-2011
Report Type: Short Report

Describes emergency department (ED) visits involving the nonmedical use of narcotic pain relievers (opioids) using data from the Drug Abuse Warning Network (DAWN). The drugs most commonly combined with narcotic pain relievers in ED visits; trends for narcotic pain relievers (2005-2011); demographic characteristics of narcotic pain reliever-related visits in 2011...

DAWN | Drug Abuse Warning Network
Collected Date: 2010-2011
Report Type: Short Report

This short report uses data on drug-related emergency department (ED) visits from the Drug Abuse Warning Network to look at 2011 ED visits involving synthetic cannabinoids. It shows trends compared to 2010 by gender, age group, the age distribution of patients, the drugs most commonly combined with synthetic cannabinoids and...

DAWN | Drug Abuse Warning Network
Collected Date: 2011
Report Type: Short Report

This Drug Abuse Warning Network (DAWN) short report shows the estimated number of emergency department visits for adverse reactions involving the pain medication tramadol between 2005 and 2011. The report specifically talks about age groups, gender, trends over time and other drugs such as cardiovascular medications, antidepressants and other pain...